Novel function of RANKL: eNOS activator

Blood

Volumn 109, Issue 4, 2007, Pages 1339-1340

  Fukumura, Dai ^a   Jain, Rakesh K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME ACTIVATOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; ENDOTHELIUM CELL; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VASCULAR ENDOTHELIUM;

EID: 33846911236     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-11-059642     Document Type: Note

References (4)

1. Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004;292:490-495.
2. Fukumura D, Kashiwagi S, Jain RK. Role of nitric oxide in tumour progression. Nat Rev Cancer. 2006;6:521-534.
3. Kim Y-M, Kim Y-M, Lee YM, et al. TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem. 2002;277:6799-6805.
4. Min J-K, Kim Y-M, Kim SW, et al. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-{kappa}B activation in endothelial cells. J Immunol. 2005;175:531-540.